FRBA vs CARE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 29, 2026
FRBA
CARE
Investment Advisor Scores
CARE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | FRBA | CARE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 8.3403 | 13.6612 | FRBA |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 1.7% | 68.3% | CARE |
| Earnings Growth | 5.1% | 253.9% | CARE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 65.7/100 | 52.5/100 | FRBA |
| Profit Margin | 31.7% | 44.9% | CARE |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG BUY | HOLD | FRBA |
Relative Price Performance (Last 90 Days)
Current Technical Phase
FRBA
DistributionPrice near a flattening SMA50 (slope 0.5%) with fading momentum, RSI 46
CARE
NeutralMixed signals - no dominant trend phase, RSI 47
Fundamentals Snapshot
| Metric | FRBA | CARE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.7 | 11.7 |
| Trailing P/E | 10.1 | 5.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.7% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | 0.4% | 0.6% |
| EPS | 1.71 | 5.80 |
| Dividend Yield | 0.02% | 0.00% |